ABSTRACT
ABSTRACT
Vaccinia virus mutants were obtained in high frequency from mouse Serial passage of animal viruses in tissue culture results in the selection of strains that have decreased cytopathogenicity in animals and are useful as live virus vaccines. The molecular mechanism(s) responsible for virus attenuation by serial passage are not well understood. One possible basis for this enrichment is that serial passage exerts a selective pressure for mutants that efficiently utilize the synthetic processes or structural elements of the host cell. Such mutants presumably would be less efficient in their utilization of the analogous processes in target cells of the natural animal host. It is also known that under certain conditions animal viruses that are normally cytocidal in tissue culture are capable of initiating and maintaining persistent infection. During the course of persistent infection numerous genetic changes occur in the virus population and the properties of the host cell may also change (1) . The genetic basis for the critical changes in the virus that permit maintenance of the persistent state is not well understood.
Our objective was to test if, by applying a stringent selective pressure for efficient replication of a poxvirus, such as vaccinia, mutants could be generated. Vaccinia virus contains a 122-megadalton (MDa) DNA, and it multiplies in the cytoplasm of infected cells, causing extensive cell damage. The virion encodes many of the enzymes necessary for viral DNA and RNA biogenesis (2), but the genetic basis for the virulence of poxviruses is not known. In this report we show that selection of vaccinia virus that replicates efficiently in persistently infected cells of the mouse Friend erythroleukemia (FEL) line resulted in enrichment for mutations with large deletions on the left terminus of genomic DNA. These mutants have greatly reduced infectivity.
MATERIALS AND METHODS
Cells and Viruses. FEL cells (a subclone of line 745A) were grown in Dulbecco's modified Eagle's medium (DME medium) containing 10% fetal calf serum and antibiotics. These cells have been previously used to study antiviral and interferon-mediated enzyme activities during infection with vaccinia virus (3). The plaque-purified WR strain of vaccinia virus was grown in HeLa S3 spinner cells at a multiplicity of 0.1 plaque-forming unit (pfu) per cell and purified essentially according to the method of Joklik (4) . The particle-to-pfu ratio was about 27 when titrated on monolayer cultures of monkey BSC-40 cells. FEL cells were infected with purified vaccinia virus at 1.0 pfu per cell. On the second and third day ofinfection >90% of the cells had died and remained attached to the dish. Surviving cells were removed by centrifugation and resuspended in fresh medium. After recovery (2-3 weeks) the cells were serially passaged every 4-5 days.
Characterization of Intracellular DNA and of Virion DNA.
Conditions for extraction of high molecular weight DNA from whole cell lysates, isolation of WR-DNA from purified virus, digestion of DNA with restriction endonucleases, gel electrophoresis, Southern blotting, and hybridization with specific nick-translated DNA probes have been previously described (5, 6) . Virus from persistently infected cells was plaque purified by selection of well-isolated plaques on monolayers of BSC-40 cells. Independent virus isolates were propagated in BSC-40 cells and virus was purified as described (7) . Where appropriate, these viruses were labeled in the DNA with [32P]orthophosphate or [3H]thymidine (7) .
RESULTS
Establishment of Vaccinia Virus Persistent Infection in FEL Cells and Generation of Viruses with Reduced Infectivity. It has been shown previously that persistent infection with vaccinia virus (strain IHD) can be established in cultures of FEL cells and that the virus produced is indistinguishable from wild-type vaccinia virus (8) . However, observations in other viral systems indicate that alterations in the vaccinia population during persistent infections might be expected to develop eventually. This prediction has been tested in infected FEL cells with the WR strain of vaccinia virus. Cells maintained continuously in culture for short and long passages were titrated for virus production in BSC-40 cells by plaque assay. Fig. 1 shows the kinetics of virus production and the appearance of plaques in these cultures. From these results, two major points can be made. First, that virus yields occur in cycles, and second, that the plaque size is progressively reduced with passage number. When virus yield reached 10-20 pfu per cell, many cells lysed. However, the surviving cells can proliferate and initiate another cycle of virus production. Under these conditions, the rate of growth of persistently infected cells was decreased compared to uninfected cells (Fig. 1 Inset) .
The extent of viral protein synthesis in persistently infected FEL cells is shown in Fig. 2 . Viral proteins were identified after immunoprecipitation with rabbit antiserum to vaccinia Abbreviations: FEL cells, Friend erythroleukemia cells; pfu, plaqueforming unit(s); VSV, vesicular stomatitis virus.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (not shown). Densitometric analysis revealed that the pattern of cellular proteins is maintained, although the (12) . Southern blots are presented in Fig. 3 . The most interesting observation is the apparent generation of deletions as detected by analysis of the HindIII digest (Fig.  3A) . In the wild-type vaccinia DNA, HindIII fragments B and C represent the right and left ends, respectively (13, 14) . With DNA from persistently infected cultures, HindIII C fragment is deleted. A series of HindIII C deletions is observed as passage number increases. However, a new fragment of about 6 MDa that is observed at early passages became dominant at late passages. Digestion of intracellular DNA with EcoRI generated a new fragment of about 5 MDa, which also became dominant at late passages (Fig. 3A) . Our strain of vaccinia virus has an extra EcoRI site at the termini, thus generating two fragments of about 4 and 2.1 MDa, of which the former is located at both ends. A third minor fragment of about 3.5 MDa is possibly derived from a small deletion in some particles present in our stock of purified vaccinia virus. Fragments of higher molecular weight than the termini of vaccinia DNA were also observed. These fragments could arise from other deletion mutants, in the course of viral DNA replication by head-head and tail-tail concatemers (15) and/or by integration with the host chromosomes (5). The nature of this DNA is not yet known. When hybridization was carried out with internal HindIII fragments I, J, and M no changes were observed in the internal structure of intracellular vaccinia DNA (Fig. 3B) Fig. 4A . This result demonstrates that there are structural alterations in the DNA of infectious virus from persistently infected cells. It can also be seen that HindIII N fragment, contiguous to HindIII C fragment, is present, indicating that the deletion is within the HindIII C fragment (Fig. 4A) . Densitometric analysis of the EcoRI fragments revealed no evidence for transposition of sequences between the ends of the viral genome (Fig. 4B) . The molar ratio of the 4-MDa band that Proc. Natl. Acad. Sci. USA 82 (1985) represents both termini of wild-type vaccinia DNA was reduced to half in DNA from virus isolates (denoted by arrow in Fig. 4B ). This is because the reduced band represents only the right terminus and a two molar (2x) band would be expected if transposition occurred between the termini of vaccinia DNA. known restriction maps of vaccinia DNA (10, 11, 16) , we have mapped the deletions between 2.2 and 3.2 MDafrom the left terminus of the vaccinia genome (Fig. 6) . We have not observed changes in the internal structure of DNAs from different virus isolates as revealed by restriction endonuclease digests with several enzymes (Fig. 4) , together with Southern blot hybridization analysis, using vaccinia HindIII fragments I, J, and M as probes (not shown).
One-step growth curves using mouse (L), monkey (BSC-40), and human (HeLa) cells infected for 24 hr with different virus isolates (5 pfu per cell) and titrated in BSC-40 cells,
showed that with all of the cell lines tested there is strong reduction in virus yields in comparison to wild-type virus (not shown): Furthermore, we have not observed persistence of vaccinia in BSC-40, HeLa, and L cells, since these infected cells died after few rounds of virus multiplication. When mutants grown in BSC-40 cells were used to infect fresh FEL cells, a persistent infection was established but the lytic effect of vaccinia virus was less than that caused by wild-type virus. Significantly, mutant virus inoculated intraperitoneally in mice resulted in greatly reduced morbidity compared to wild-type virus. These mutant viruses elicit an immune response lower than wild-type virus, which fully protects mice challenged with a lethal dose of wild-type virus (unpublished data). These experiments confirm that the vaccinia deletion mutants generated in FEL cells have reduced infectivity. - (8) , who reported no changes in the vaccinia virus population during the course of persistent infection. How these differences are related to the virus strain and the cell line used is not known. In the vaccinia-FEL system, interference between the endogen'ous RNA virus and vaccinia virus has been proposed as a mechanism for the establishment of persistent infection (8 (17) . The length of this region is unstable and the region can be reiterated many times, a process apparently mediated by recombinational events (9, 24) . As indicated in Figs. 4 and 5, we have observed deletions in some mutants (clone 21) duplication of up to 400 base pairs in others (clones 3 and 7), and no change in the length of tandem repeats (clone 12) compared to the ends of wild-type vaccinia DNA. Significantly, neither the previously .described 6.3-MDa deletion nor the small deletions appear to be required for virus infectivity as measured in tissue culture cells (10, 11) , while mutant viruses generated in FEL cells have larger deletions and reduced infectivity.
Several mechanisms have been proposed to explain deletion formation (15, (25) (26) (27) . Deletions could be produced by a recombination mechanism within short repeated sequences (26) present at the left terminus of the viral genome, by illegitimate recombination (27) , or by both. How these deletions alter virus infectivity is not yet known. Since DNA replication is a multienzyme process (28), the possibility exists that the rate and extent of vaccinia DNA synthesis is reduced in cells infected with these mutants because specific regions are missing within the inverted terminal repetition. Alternatively, mutations within other regions of the viral genome could limit virus-cell interactions.
Vaccinia virus is now being used as a eukaryotic cloning and expression vector and, eventually, it might be used as a polyvalent vaccine (29, 30) . The construction of attenuated mutant viruses should facilitate studies on the genetic basis of virulence of poxvirus. In addition, there is the possibility of generating mutant viruses less efficient in the utilization of the synthetic processes or structural elements of the host cell. These mutants could be used to study the biochemistry of poxvirus-cell interactions and could be of considerable practical value in constructing recombinant vaccinia viruses suitable for use as vaccines without the usual risks associated with wild-type vaccinia virus.
